Testing for drugs of abuse in children and adolescents

R. B. Heyman, Jr Adger H., T. M. Anglin, Jr Fuller, E. A. Jacobs, R. Z. Shah, M. Tenenbein, M. Armentano, G. M. Boyd, D. Czechowicz, M. Schydlower

Research output: Contribution to journalReview articlepeer-review

55 Scopus citations

Abstract

The American Academy of Pediatrics (AAP) recognizes the abuse of psychoactive drugs as one of the greatest problems facing children and adolescents and condemns all such use. Diagnostic testing for drugs of abuse is frequently an integral part of the pediatrician's evaluation and management of those suspected of such use. 'Voluntary screening' is the term applied to many mass non-suspicion-based screening programs, yet such programs may not be truly voluntary as there are often negative consequences for those who choose not to take part. Participation in such programs should not be a prerequisite to participation in school activities. Involuntary testing is not appropriate in adolescents with decisional capacity-even with parental consent-and should be performed only if there are strong medical or legal reasons to do so. The AAP reaffirms its position that the appropriate response to the suspicion of drug abuse in a young person is the referral to a qualified health care professional for comprehensive evaluation.

Original languageEnglish (US)
Pages (from-to)305-307
Number of pages3
JournalPediatrics
Volume98
Issue number2
StatePublished - Aug 1996
Externally publishedYes

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint

Dive into the research topics of 'Testing for drugs of abuse in children and adolescents'. Together they form a unique fingerprint.

Cite this